Valvular heart disease in hyperprolactinemic patients treated with low doses of cabergoline.
Servicio de Cardiología, Hospital General Universitario de Albacete, Albacete, Spain. Electronic address: jgcordobas@hotmail.com.
Juan G
JG
Córdoba-Soriano
Servicio de Endocrinología, Hospital General Universitario de Albacete, Albacete, Spain.
Cristina
C
Lamas-Oliveira
Servicio de Cardiología, Hospital General Universitario de Albacete, Albacete, Spain.
Víctor M
VM
Hidalgo-Olivares
Servicio de Cardiología, Hospital General Universitario de Albacete, Albacete, Spain.
Antonia
A
Tercero-Martínez
Servicio de Cardiología, Hospital General Universitario de Albacete, Albacete, Spain.
Moisés
M
Barambio-Ruíz
Servicio de Cardiología, Hospital General Universitario de Albacete, Albacete, Spain.
Jesús
J
Salas-Nieto
D000328:Adult; D000077465:Cabergoline; D004873:Ergolines / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D004873:Ergolines; D000077465:Cabergoline